Entry8.76→Now3.76
Hold MEDS on AI cancer diagnostics catalyst Open original source
MEDS DataMeds AI, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
14:53
Sep 16
Sep 16
Hold MEDS on AI cancer diagnostics catalyst
The author notes that MEDS acquired an AI cancer diagnostics lab and intends to hold the position. The rationale is that a cancer-related catalyst has historically driven large stock moves, implying similar upside potential here. The main risk is reliance on a historical pattern rather than company-specific fundamentals.
MED
About MEDS Investor Commentary
Across the available history and selected sources, Buzzberg tracks MEDS (DataMeds AI, Inc.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: u/Glittering_Dig3798.